Delek Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $21.5M | Buy |
167,933
+25,000
| +17% | +$3.2M | 0.83% | 41 |
|
|
2019
Q1 | $19.2M | Sell |
142,933
-19,000
| -12% | -$2.56M | 0.8% | 43 |
|
|
2018
Q4 | $16.2M | Buy |
161,933
+37,755
| +30% | +$3.77M | 0.74% | 41 |
|
|
2018
Q3 | $17.2M | Sell |
124,178
-10,000
| -7% | -$1.38M | 0.72% | 39 |
|
|
2018
Q2 | $16.7M | Buy |
134,178
+30,000
| +29% | +$3.72M | 0.71% | 41 |
|
|
2018
Q1 | $11.6M | Buy |
104,178
+18,000
| +21% | +$2.01M | 0.6% | 51 |
|
|
2017
Q4 | $10.3M | Buy |
+86,178
| New | +$10.3M | 0.55% | 55 |
|